The melioidosis bacterium, Burkholderia pseudomallei, is increasingly being recognized as a 21 pathogen in patients with cystic fibrosis (CF). We have recently catalogued genome-wide 22 variation of paired, isogenic B. pseudomallei isolates from seven Australasian CF cases, which 23 were collected between four and 55 months apart. Here, we extend this investigation by 24 documenting the transcriptomic changes in B. pseudomallei in five cases. Following growth in 25 an artificial CF sputum medium, four of the five paired isolates exhibited significant differential 26 gene expression (DE) that affected between 32 and 792 genes. The greatest number of DE 27 events was observed between patient CF9 strains, consistent with the hypermutator status of 28 the latter strain, which is deficient in the DNA mismatch repair protein MutS. Two patient 29 isolates harbored duplications that concomitantly increased expression of the β-lactamase gene 30 penA, and a 35kb deletion in another abolished expression of 29 genes. Convergent expression 31 profiles in the chronically-adapted isolates identified two significantly downregulated and 17 32 significantly upregulated loci, including the antibiotic resistance-nodulation-division (RND) efflux 33 pump BpeEF-OprC, the quorum-sensing hhqABCDE operon, and a cyanide-and pyocyanin-34 insensitive cytochrome bd quinol oxidase. These convergent pathoadaptations lead to 35 increased expression of pathways that may suppress competing bacterial and fungal pathogens 36 and that enhance survival in oxygen-restricted environments, the latter of which may render 37 conventional antibiotics less effective in vivo. Treating chronically-adapted B. pseudomallei 38 infections with antibiotics designed to target anaerobic infections, such as the nitroimidazole 39 class of antibiotics, may significantly improve pathogen eradication attempts by exploiting this 40 Achilles heel. 41 42 2015). Impaired immunity and mucus clearance encourage infection and subsequent 59 persistence and adaptation of opportunistic bacterial pathogens in the CF lung, leading to the 60 development of bronchiectasis with subsequent progressive pulmonary decline, and ultimately, 61 loss of pulmonary function and death (Cohen and Prince 2012). 62 The most common pathogens of the CF lung comprise Pseudomonas aeruginosa, 63 Staphylococcus aureus, Haemophilus influenzae, and less commonly, Achromobacter 64 xylosoxidans, non-tuberculosis mycobacteria, Stenotrophomonas maltophilia and certain 65 Burkholderia species, including B. cepacia complex species and B. pseudomallei (Coutinho et 66 Figure 1. Degust volcano plots showing differentially expressed (DE) genes between paired 110 Burkholderia pseudomallei isolates retrieved from five cystic fibrosis (CF) lungs, and between 111 initial and latter isolates. Four of the five pairs exhibited DE; CF10, with the shortest time 112 between isolates, exhibited no genetic or significant transcriptomic changes. CF6, CF8, CF9 113 and CF11 pairs were separated by 229, 32, 792 and 169 DE loci, respectively. The 32 DE loci in 114 CF8 were all downregulated; DE genes in CF6, CF9 and CF11 were down-or up-regulated. 115
INTRODUCTION 43
The Gram-negative soil-dwelling bacterium Burkholderia pseudomallei causes melioidosis, an 44 opportunistic tropical infectious disease of humans and animals that has a high fatality rate 45 (Wiersinga et al. 2012 ). B. pseudomallei is found in many tropical and subtropical regions 46 globally, and has been unmasked in temperate and even arid environments following unusually 47 wet weather events (Yip et al. 2015 ; Chapple et al. 2016; Sarovich et al. 2016 ). Infection occurs 48 following percutaneous inoculation from contaminated soil or water, inhalation, or ingestion. 49
Melioidosis symptoms vary widely due to the ability for B. pseudomallei to infect almost any 50 organ, with pneumonia being the most common presentation (Leelarasamee and Bovornkitti 51 1989; Currie et al. 2010) . Individuals most at risk of contracting melioidosis include diabetics, 52 those with hazardous alcohol consumption, and the immunosuppressed. There has been 53 increasing recognition that people with chronic lung diseases such as cystic fibrosis (CF) are 54 also at a heightened risk (Holland et al. 2002; O'Carroll et al. 2003) . 55 CF is a heritable disorder of the CFTR gene, and defects in CFTR lead to exaggerated and 56 ineffective airway inflammation, an imbalance in salt regulation in the lungs and pancreas, and a 57 chronic overproduction of thick and sticky mucus in the airways and digestive system (Amaral 58 al. 2008 ). The most common and best-studied CF pathogen is P. aeruginosa, which can adapt 67 to the CF lung environment via various mechanisms. Convergent pathoadaptations in P. 68 aeruginosa include the downregulation or loss of virulence factors and motility-encoding loci, 69 emergence of hypermutators, enhanced antibiotic resistance and immune evasion facilitated by 70 a switch to mucoidy and a biofilm-based lifestyle, and altered expression of other loci enhancing 71 bacterial metabolism and survival within the nutrient-poor CF lung environment (Cohen and 72 Prince 2012; Winstanley et al. 2016) . 73
Improving life expectancy for those with CF has led to an increased risk of exposure to B. 74 pseudomallei following travel to melioidosis-endemic regions. Although uncommon, infection of 75 the CF lung by B. pseudomallei has now been documented in at least 25 cases worldwide 76 (Geake et al. 2015 ). Due to low total case numbers, comparatively little is understood about the 77 pathogenic role of B. pseudomallei in CF pulmonary disease. The most common clinical 78 presentation is chronic carriage (76%), which is associated with accelerated lung function 79 decline (Geake et al. 2015) . This prevalence contrasts with melioidosis in non-CF patients, 80
where chronic carriage is exceedingly rare, occurring in only 0.2% of cases (Price et al. 2015) . 81
To better understand B. pseudomallei pathoadaptation in the CF lung, we recently investigated 82 the genome-wide evolution of isogenic B. pseudomallei strains isolated from seven Australasian 83 CF patients, which were collected between 4 and 55 months apart (Viberg et al. 2017) . 84
Hallmarks of these infections included B. pseudomallei persistence despite multiple eradication 85 attempts, multidrug resistance, mutations in virulence, metabolism and cell wall components, 86 and the first-documented case of hypermutation in B. pseudomallei. In all except one case, 87 multiple single-nucleotide polymorphism (SNP) and insertion-deletion (indel) mutations were 88 identified, with a high rate of nonsynonymous mutations, many of which were predicted to affect 89 protein function (Viberg et al. 2017) . 90
RNA-seq provides a detailed view of the transcriptional landscape in bacterial isolates grown 91 under different conditions or niches (Sharma et al. 2010) , and is now a well-established method 92 for examining differential gene expression (DE) in bacterial pathogens (Creecy and Conway 93 2015) . Here, we performed bacterial RNA-seq on five of the CF cases that we have recently 94 
RESULTS 100
Differential gene expression among CF isogenic pairs. DE was observed in four of the five 101 CF pairs, with only the CF10 pair failing to yield significant transcriptional differences (i.e. no 102 genes with a ≥1.5 log2-fold change and a false discovery rate (FDR) of ≤0.01; Figure 1 ). We 103 have previously shown that no genetic variants separate the CF10 strains, which had the 104 shortest time between collection of only 10 months (Viberg et al. 2017 ). This lack of significant 105 transcriptional differences rules out epigenetic effects on gene expression between this pair, at 106 least under the tested growth conditions, and illustrates that RNA-seq is a robust methodology 107 that is not readily prone to false-positive results. 108 109 pairs (Pearson's Χ 2 test p<0.001), with between 63 and 97% of the DE genes residing on 134 chromosome II. In CF9, there was a non-significant trend towards chromosome II loci, with 52% 135 of DE loci located on this chromosome, pointing to the more random nature of mutations in the 136 CF9 hypermutator compared with the other cases (Table S1) . 137 (092700E 11, 2000031063,  164   2000031281, 2002721280, 6, A188, A193, ATCC10399 , ATCC23344, BMQ, China5, 165
China7, FMH23344, GB8horse4, JHU, and PRL-20), there was a 23, 27, 33 and 100% overlap 166 with DE genes in the latter isolates from CF9, CF6, CF11 and CF8, respectively, and when 167 compared with genes lost in MSHR6686, there was a 9, 15, 20 and 97% overlap, respectively 168 (Table S1 ). The proportion of downregulated genes varied across this dataset, ranging from 169 13% for CF11 to 100% for CF8, demonstrating that the effect on gene expression at these loci 170
is not unidirectional, with certain overlap loci in fact being upregulated in CF6, CF9 and CF11. 171 Of note, all 29 genes (BPSS1131-BPSS1159) that were lost due to a large deletion in the latter 172 with forty-six downregulated surface polysaccharide genes (Table S1) . 188
The LPS loci wbiE (BPSL2676) and wbiD (BPSL2677) were downregulated by ~1.8-fold (3x) in 189 the latter CF9 isolate. In addition, the poorly characterized LPS biosynthesis-related membrane 190 protein loci BPSS1683-BPSS1685 were downregulated by ~5.9-fold (60x). This isolate also 191 exhibited downregulation of all CPS-I loci (except wcbC) by between 1.7-and 3.1-fold (3 to 8x). 192
In contrast, the latter isolate from CF11 showed upregulation of the CPS-I loci BPSL2793-193 BPSL2797 (wcbN-wcbM-gmhA-wcbL-wcbK) when compared with its initial isolate, with 194 increases ranging from 2.7 to 6.1-fold (7 to 69x). However, when compared with initial isolates 195 from CF6, CF8, CF9 and CF10, expression of BPSL2793-BPSL2797 in the latter CF11 strain 196 was in fact downregulated (3.4 to 4.5-fold; 11 to 23x). This observation was confirmed as 197 significant downregulation of these loci in the initial CF11 strain (by between 6.1-and 10.1-fold; 198 69 to 1,098x) when compared with all other initial strains, rather than significant upregulation of 199 these CPS-I loci in the latter CF11 strain. 200
Unlike CPS-I, expression of the CPS-II cluster (BPSS0417-BPSS0429) is induced when grown 201 in water, suggesting that this polysaccharide plays a role in environmental survival Zenteno et al. 2010). One locus involved in CPS-II biosynthesis, BPSS0425, was 203 downregulated (1.8-fold; 4x) in CF6, and the entire cluster was downregulated in CF9 (range: 204 2.5-to 5.2-fold; 6 to 37x). Conversely, BPSS0417 and BPSS0418 were upregulated in CF11 205
(1.6-and 1.7-fold; 3x), respectively. However, as with CPS-I, both CF11 strains exhibited 206 significant downregulation of BPSS0417 and BPSS0418 when compared with initial strains from 207 CF6, CF8, CF9 and CF10 (2.0-and 3.1-fold; 4 to 9x). The genes encoding CPS-III (BPSS1825-208 BPSS1835) were significantly downregulated in the latter isolates from CF6 (2.4-to 3.1-fold; 5 209 to 9x) and CF9 (5.6-to 7.5-fold; 50 to 178x). Finally, two genes within the CPS-IV cluster 210 (BPSL2769-BPSL2785) were downregulated in CF9 (BPSL2782 and BPSL2785; 1.8-to 2.8-211
fold; 3 to 7x) but 11/17 loci from this cluster were upregulated in CF11 by 1.7-to 5.9-fold 212 (BPSL2769, BPSL2775-BPSL2784). However, unlike CPS-I and CPS-II, this pattern of 213 upregulation in both CF11 isolates was maintained for CPS-IV loci BPSL2769 and BPSL2775-214 Consistent with loss-of-virulence as a pathoadaptive mechanism in chronic B. pseudomallei 224 infections, we have previously documented missense mutations affecting the Type 3 secretion 225 system 3 (T3SS-S) gene bsaW in CF6, and Burkholderia biofilm factor A bbfA and fimbrial 226 protein BPSL1628 in CF9 (Viberg et al. 2017 ). When examining RNA-seq profiles, other 227 virulence genes lacking genetic mutations were found to be significantly downregulated in the 228 latter CF isolates. These loci included three Type IV pilus 7 (TFP7) loci (pilR, pilG and pilN; 1.7-229 fold; 3x), the lysozyme inhibitor BPSL1057 (3.4-fold; 11x), Burkholderia lethal factor 1 (3.2-fold; 230 10x), four T3SS-3 loci (bsaS, bsaP, bsaO and bsaN), and 16 flagellum loci in CF9 (average 2.5-231 fold; 6x), and a trimeric autotransporter adhesin (bpaC; BPSL1631) in CF11 (1.6-fold; 3x). Of 232 these, the four T3SS-3 loci are also missing in chronic P314 isolates. 233
Several regulators with decreased transcription in the CF isolates are absent in B. mallei. 234
We hypothesized that downregulation of transcriptional regulators, particularly those absent in 235 B. mallei, would be identified in the latter CF isolates due to niche adaptation. As predicted, two 236 of the four pairs exhibited significant downregulation of transcriptional regulators. The first of 237 these, the Fis family regulatory protein YfhA (encoded by BPSL0350), was downregulated by 238 ~2.7-fold (~7x) in both CF6 and CF9. In E. coli, Fis is a global regulator that is induced under 239 nutrient-rich conditions and plays a role in the regulation of myriad processes including the 240 initiation of DNA replication, ribosomal RNA transcription activation and capsule expression 241 BpeS (BPSL0731). We therefore expected to observe upregulation of bpeEF-oprC in CF strains 257 with elevated TMP/SMX MICs, consistent with defective bpeT or bpeS loci. 258
The latter isolate from CF6, which encodes a T314fs mutation in bpeT and is highly resistant 259 towards TMP/SMX (MIC ≥32 µg/mL), showed 5.2 to 6.8-fold upregulation of bpeEF-oprC (38 to 260 111x; Table S1 ). This isolate also harbours an R20fs mutation in ptr1 (BPSS0039; folM), which 261 encodes a pteridine reductase that is involved in TMP/SMX resistance (Podnecky et al. 2017) ; 262 this frameshift truncates Ptr1 from 267 to 91 residues. Both strains isolated from CF11 are also 263 highly resistant to TMP/SMX (MIC ≥32 µg/mL) and encode the BpeS missense variants V40I increased by 4.5-fold (22x) in the latter CF6 strain. Six proximal genes (BPSS0945; BPSS0948-281 BPSS0952) were also upregulated by 3.1-to 4.7-fold (9 to 26x; Table S1 ). One of these, 282 BPSS0945, is a peptidase and a putative virulence factor that may play a role in multinucleated 283 giant cell formation (Singh et al. 2013) . 284
A gene duplication event encompassing penA has also been documented in the CF11 isolates. 285
The initial strain showed an elevated MIC towards CAZ (12 µg/mL), corresponding with a ~10x 286 duplication of a 36.7kb region that includes penA, whereas the latter strain had a 2x duplication 287 of this region and a wild-type CAZ MIC (2 µg/mL) (Viberg et al. 2017 ). As expected, penA was 288 downregulated by 2.1-fold (4x) in the latter isolate due to five times fewer copies of this gene. 289
Downregulation of other genes within the 36.7kb locus ranged from 1.4 to 3.3-fold (3 to 10x; 290 Table S1 ). Both CF11 strains encode a large deletion in amrR (amrR ΔV62-H223 ). This mutation results in a 301 2.6-to 3.2-fold (6 to 9x) upregulation of amrAB-oprA in these isolates. In addition, a previously 302 undocumented S130L mutation in BPSL3085 likely contributes to the decreased susceptibility 303 observed towards doxycycline. 304
Evidence of convergent DE between early and latter CF isolates. Finally, we performed a 305
comparison of expression profiles from all CF cases to identify a signal of convergent gene 306 expression (pathoadaptation) across early vs latter isolates. To yield the most robust and 307 relevant analysis, we excluded the latter isolate from CF10 due to a lack of DE in this strain, and 308 the initial isolate from CF11, which was retrieved >3 years after infection and had already 309 undergone substantial genetic and transcriptional modifications. Exclusion of both strains was 310 supported by a lack of convergent signal when they were included in the analysis (data not 311 shown). Using these parameters, 17 genes were found to be significantly upregulated, and two 312 were significantly downregulated (Table S2 ). Five (26%) loci encode for hypothetical proteins 313 with no known function, of which four were upregulated. Among the convergently upregulated 314 genes with known function was the RND efflux pump BpeEF-OprC (4.8-to 6.1-fold; 28 to 69x), 315
the CydAB cytochrome bd quinol oxidase (5.5-to 5.9-fold; 45 to 60x), and the quorum sensing The causative agent of the tropical disease melioidosis, B. pseudomallei, is an uncommon 321 pathogen in CF, with fewer than 30 cases documented worldwide to date (Geake et al. 2015) . 322
We have recently performed comparative genomic analysis of isogenic strains collected 323 between 4 and 55 months apart from the airways of seven of these cases (Viberg et al. 2017) . 324
Here, we sought to further characterize these chronic cases by examining the transcriptomes of 325 five paired B. pseudomallei isolates retrieved between 10 and 55 months apart. Isolates were 326 cultured in an artificial CF sputum medium (Fung et al. 2010 ) to mimic their original in vivo 327
environment. 328
Under these conditions, DE was detected in four of the five cases and ranged from 32 to 792 329 genes, with the hypermutator strain from CF9 contributing the greatest number of DE loci ( Table  330 S1). Interestingly, when compared with the number of genetic changes occurring in each isolate 331 pair, the latter isolate from CF11 had a higher proportion of DE loci to mutations (11.3) than CF9 332 (7.1), demonstrating that hypermutation does not necessarily lead to a similarly high number of 333 transcriptional differences. The one case with no DE, CF10, exhibited no genetic changes (i.e. 334
SNPs, small indels, copy-number variants, or large deletions) and had the shortest time 335 between isolate collection at 10 months (Viberg et al. 2017 ). All other cases encoded genetic 336 differences between pairs. The DE genes fell into several functional categories (Table S1) , 337
reflecting the diversity and versatility of pathoadaptive pathways in B. pseudomallei. Our RNA-338 seq analysis revealed that many of the DE genes were absent in the chronic P314 strain (range: 339 9-97%) or in B. mallei (range: 23-100%), providing further evidence that these loci are not 340 required for long-term survival in the human airways. Perhaps most striking was the observation 341 that nearly one-third (32%) of DE genes lack a known function, highlighting the relative paucity 342 of functional studies into this important yet under-recognized pathogen. gmhA-wcbL-wcbK in both CF11 isolates. In both cases, it is likely that CPS-I production was 380 either substantially reduced or abolished. Although CPS-III is not required for virulence, it is 381 noteworthy that this locus was also downregulated in CF9 and CF11, as it has been previously 382
shown that CPS-III expression is tied to that of CPS-I genes (Ooi et al. 2013) . and BPSS1683-BPSS1685. The convergent evolution of the chronic strains to attenuate CPS-I 391 and LPS loci demonstrates the dispensable, and probably highly unfavourable, nature of these 392 surface antigens for long-term survival of this pathogen in the CF airways. Prior work has 393 suggested that CPS-I and LPS may be disadvantageous for B. pseudomallei persistence due to 394 their virulence potential and immunogenicity (Price et al. 2013 ). By examining both genomic and 395 transcriptomic modifications over time, it is now clear that these capsule clusters, in their wild-396 type form, pose a major issue for successful long-term B. pseudomallei persistence in the CF 397 lung, with the bacterium either mutating or downregulating key genes in CPS-I and LPS 398 pathways. We also observed genetic mutation or transcriptional downregulation of other 399 virulence genes in latter CF strains including TFP7 loci, Burkholderia lethal factor 1, T3SS-3 loci 400 and flagellum loci, suggesting that these loci are similarly detrimental to long-term B. 401 pseudomallei survival in the human host. Importantly, the RNA-seq data identified additional 402 cases of surface antigen and virulence factor abrogation that were not observable with only 403 genomic data. This finding underscores the importance of using both genomic and 404 transcriptomic approaches to identify the functional consequences of within-host evolution of 405 chronic bacterial infections. 406 TMP/SMX is used during the eradication phase of melioidosis treatment and is recommended 407 for post-exposure prophylaxis (Peacock et al. 2008) . We have previously shown that the latter 408 isolate from CF6, and both isolates from CF11, had developed high-level (≥32 µg/mL) 409 TMP/SMX resistance over the course of treatment. These elevated MICs were proposed to be 410 due to mutations within BpeEF-OprC efflux pump regulators (BpeT T314fs in CF6, and BpeS 411 V40I and R247L in CF11) alongside mutations affecting the R20 residue of Ptr1/FolM (R20fs in 412 CF6; R20-A22 duplication in CF11) (Viberg et al. 2017) . Here, we have demonstrated that the 413 efflux pump regulatory mutations cause a dramatic upregulation of bpeEF-oprC in these strains 414 of between 5.2-and 6.9-fold (38 to 121x), mirroring expression levels in bpeS and bpeT lab-415 generated mutants with high-level TMP/SMX resistance (Podnecky et al. 2017 ). Our results 416 confirm those of Podnecky and colleagues (Podnecky et al. 2017) showing that upregulation of 417 bpeEF-oprC via BpeS or BpeT dysregulation, together with Ptr1/FolM alteration, leads to a 418 significant increase in TMP/SMX MICs that would render this antibiotic ineffective in vivo. RNA-419 seq is thus a useful tool for confirming the functional consequences of regulatory mutations that 420 control RND efflux pump expression. 421
In addition to TMP/SMX resistance, the initial isolate from CF11 is resistant to CAZ (12 µg/mL) 422 and the latter isolate from CF6 is highly resistant to CAZ (≥256 µg/mL). Our prior genomic study 423 showed that CAZ resistance in the initial CF11 strain was due to a 10x duplication of a 36.7kb 424 region encompassing the β-lactamase gene, penA, the first time that gene duplication has been 425 shown to confer CAZ resistance in B. pseudomallei (Viberg et al. 2017) . In contrast, a 2x 426 duplication of this region in the latter strain did not raise the CAZ MIC above wild-type levels 427 transcriptional changes provides a potential means to predict pathogen behavior and evolution 442 across multiple CF cases in a relatively straightforward manner. Such predictability could 443 conceivably be exploited to improve the diagnosis or treatment of intractable CF infections, or 444 ideally, to prevent them from progressing in the first place. Therefore, a major objective of this 445 study was to identify evidence of convergence in B. pseudomallei gene expression during its 446 transition to a chronic infection. Despite the small number of CF melioidosis patients available 447 for this study, a signal of convergent pathoadaptation was identified between the initial and latter 448 isolates, with 19 significantly DE loci identified, 17 of which were upregulated (Table S2 ). This 449 convergence is noteworthy given the large size of the B. pseudomallei genome and the many 450 redundant pathways that could lead to similar adaptive phenotypes, a phenomenon that is well-451 recognized in P. aeruginosa (Marvig et al. 2015) . One advantage of identifying convergence 452 using transcriptomics rather than genomic data is that it can reveal the transcriptional 453 consequence of multiple genetic mutations; for example, we have observed that multiple 454 high-dose antibiotic therapy (Viberg et al. 2017 ). It was therefore not surprising to identify the 462 convergent upregulation of bpeEF-oprC (4.8-to 6.1-fold; 28 to 69x), which was significantly 463 upregulated in two of the four patients with DE (CF6 and CF11), and which led to TMP/SMX 464 resistance as discussed above. The second convergently upregulated locus was the cydAB 465 operon (BPSL0501 and BPSL0502) , which encodes for cytochrome bd quinol oxidase (5.5-to 466 5.9-fold; 45 to 60x); this locus was significantly DE in CF6 and CF9. CydAB is an aerobic 467 terminal oxidase that oxidizes ubiquinol-8 and reduces oxygen to water under oxygen-limiting 468 conditions. This enzyme is better able to scavenge oxygen under microaerobic conditions 469 compared with cytochrome o oxidase, which otherwise predominates as the terminal respiratory 470 enzyme in electron transport-associated energy production (Cotter et al. 1997 ). Voggu and 471 colleagues demonstrated that the cydAB loci encoded by non-pathogenic Staphylococcus 472 species were better able to resist P. aeruginosa antagonism in the CF lung compared with the 473 cydAB loci encoded by S. aureus. This resistance was imparted by an insensitivity of the non-474 pathogenic staphylococci cytochrome bd quinol oxidases to the presence of the small 475 respiratory inhibitors hydrogen cyanide and pyocyanin, which are commonly secreted by P. 476 aeruginosa in the CF lung. In contrast, Voggu et al. showed that S. aureus was exquisitely 477 sensitive to the co-presence of P. aeruginosa due to their less resistant cydB locus, which is 478 inhibited by these small respiratory inhibitors (Voggu et al. 2006 ). Thus, it is feasible that the 479 convergent upregulation of cydAB loci represents a defense mechanism employed by B. 480 pseudomallei to counteract the toxic effects of small respiratory inhibitors produced by P. 481 aeruginosa in the CF lung. In support of this hypothesis, P. aeruginosa was co-isolated in all five 482 CF cases examined in this study (Viberg et al. 2017) . Alternatively, cydAB upregulation may 483 simply represent a physiological response to the oxygen-limited environment of the CF airways, 484 as its expression is known to be induced in B. pseudomallei in hypoxic conditions (Hamad et al. 485 2011) . Under such conditions, many pathogens including B. pseudomallei become less 486 susceptible to conventional antibiotics, which are typically more effective under aerobic 487 conditions, but more susceptible to antibiotics that target anaerobic infections, such as the 488 Of the two convergently downregulated loci, only one, BPSS0351, has an assigned function, 515
although little is known about the role of this gene and its product in B. pseudomallei. This gene 516 encodes CueR (3.4-fold; 11x), a MerR family copper response regulator that is highly sensitive 517 to the presence of copper (Cu) and which regulates the transcription of genes that protect 518 against toxic metal ion concentrations (Brown et al. 2003; Singh et al. 2004 ). Cu has a long 519 history as an effective antimicrobial agent due its ability to generate reactive oxygen species, 520
with Cu accumulation in the mammalian host purported to act as an innate immune defense 521 mechanism to restrict pathogen growth (Samanovic et al. 2012 ). Thus, downregulation of cueR 522 in the latter CF isolates may represent a mechanism for mitigating Cu toxicity in the host, 523 similarly to E. coli (Singh et al. 2004 ). However, there are contradictory reports as to whether Cu Castle Hill, NSW, Australia) dissolved in 40 mL ultrapure water was autoclaved prior to use. All 574 other solutions were sterilized using a 0.22 µM vacuum filter, apart from the UV-irradiated egg 575 yolk emulsion (Oxoid, Thebarton, SA, Australia), which was treated aseptically. A stock solution 576 of diethylenetriaminepentaacetic acid (Sigma-Aldrich) was made by dissolving 59.5 mg into 5 577 mL of very basic water (pH=14). CaCl2 was added at a final concentration of 0.22 g/L (J. Manos, 578 pers. comm.). Final concentrations of the components were: 10 g/L mucin, 1.39 g/L salmon 579 sperm DNA (Sigma-Aldrich), 5 g/L NaCl, 2.2 g/L KCl, 0.22 g/L CaCl2, 5 g/L casein acid 580 hydrosylate (Sigma-Aldrich), 10 g/L bovine serum albumin (Roche Diagnostics, Castle Hill, 581 NSW, Australia), 0.005% diethylenetriaminepentaacetic acid, and 0.5% of egg yolk emulsion. 582
Each batch was tested for sterility prior to use by plating 100 µL onto Luria Bertani (LB) agar 583 (Oxoid) and incubating aerobically for 24 h. pH was tested using an aliquot of the medium to 584 ensure it was within the desired range (pH ~6.5-7). The medium was stored at 4 o C for no 585 longer than four weeks prior to use. 586 Viability counts. Two sets of viability counts were performed for this study. The first was 587 conducted to determine the number of colony-forming units (cfu) at OD590, which enabled us to 588 standardize the starting number of cells inoculated into the artificial sputum medium. The 589 second was conducted to verify the final concentration of cells across all CF isolates, which 590 enabled us to determine the number of cells for nucleic acid extraction to ensure that 591 approximately equal cell amounts were processed for each pair. The CF isolates were 592 subcultured from glycerol stocks onto LB agar at 37 o C for 24 h. Cells were suspended into 593 phosphate-buffered saline (PBS) followed by spectrophotometric measurement at OD590=1.0 in 594 a WPA CO 8000 cell density meter (Biochrom Ltd, Blackburn, VIC, Australia). Tenfold dilutions 595 and plating of cultures onto LB agar was carried out, followed by enumeration at 24 h. Viable 596 counts demonstrated that all CF isolates exhibited similar cell density when normalized to an 597 OD590=1.0 (range 1.3x10 8 to 4.9x10 8 ). Based on these counts, the starting amount of culture for 598 the CF isolates was standardized to 10 5 cfu for all subsequent experiments. 599
Growth curves in the artificial sputum medium. To minimize laboratory passage, each 600 culture was again subcultured from the original glycerol stocks onto LB agar at 37 o C for 24 h, 601 followed by a replication of OD590 measurements as determined previously. Based on the 602 viability count data, samples were then diluted to 10 6 cfu/mL in PBS. One hundred µL of this 603 suspension (~10 5 cfu) was used to inoculate 1.9 mL of the sputum medium, which was 604 aliquoted into 14 mL Nunc round-bottom culture tubes (Thermo Fisher Scientific, Scoresby, VIC, 605 Australia). Due to biosafety concerns, cells were grown in closed-capped tubes, and were 606 incubated at 37 o C by shaking in an orbital incubator shaker (model BL8500; Bioline, Eveleigh, 607 NSW, Australia) at 50, 200 or 230 rpm for 44 h. Growth curves were obtained by measuring 608 OD590 at regular intervals over this period using un-inoculated sputum medium as the control 609 blank. Shaking at 50 rpm was initially performed to mimic the low-oxygen conditions of the CF 610 lung; however, this speed caused heavy sedimentation of cells and media components, and 611 biofilm formation at the aerobic interface, both of which led to a decrease in OD values over 612 time and unpredictable, non-uniform growth. Similarly, shaking at 230 rpm was too vigorous for 613 the cells, as observed by inconsistent, non-reproducible viable counts. When shaking at 200 614 rpm, highly reproducible OD values that correlated with viability counts were obtained (Figure  615 S1), and the medium did not readily sediment. We therefore used this speed for subsequent 616 experiments, including for RNA harvest. Viability counts were performed at the time of harvest 617 to ensure uniformity of cell concentrations across all isolates. 618 RNA extraction from isolates grown in the artificial sputum medium. The CF strains were 619 grown in duplicate at 200 rpm as detailed above. Based on the growth curve analysis, nucleic 620 acids for all cultures were extracted at late log phase (17 h). At the point of harvest, the OD590 of 621 each replicate was measured to ensure that consistent cell density had been obtained prior to 622 combining replicates; final viability counts were also performed. Due to the highly labile nature 623 of bacterial mRNA, two 100 µL aliquots for each strain were immediately placed into 200 µL of 624 RNAprotect (Qiagen, Doncaster, VIC, Australia) and incubated for 5 min to preserve their 625 transcription profiles. Cells were pelleted by centrifugation at 5000 x g for 10 min, and the 626 supernatant discarded. Total RNA was extracted using the RNeasy Protect Bacteria Mini Kit 627 (Qiagen). B. pseudomallei cells were lysed following the protocol for genomic DNA extraction 628 (Currie et al. 2007 ), with an extended incubation time in Proteinase K to 1.5 h. Lysates were 629 loaded onto the RNeasy mini columns and extractions were carried out according to the 630 manufacturer's instructions, including the recommended on-column DNase I digestion. In our 631 hands, we found this DNase I treatment to be insufficient for removing all contaminating DNA. 632
Extractions for RNA-seq were therefore further treated with TURBO DNA-free kit (Ambion, 633
Scoresby, VIC, Australia). For each sample, 35 µL of extracted RNA was incubated with 6 U 634 TURBO DNase at 37 o C for 32 min. The remaining RNA was not treated with this second round 635 of DNase; instead, this sample was used as template for PCR contamination screening, as 636 isolates vs. all latter CF isolates, with the latter CF10 isolate excluded due to a lack of DE in this 685 strain and the initial CF11 isolate excluded due to >3 years of infection prior to its isolation 686 (Viberg et al. 2017 ). For all analyses, DE was defined as a log2 fold change of ≥1.5 and a false 687 discovery rate of ≤0.01. To improve visualization of DE loci in the volcano plot of the initial and 688 latter comparison (Figure 1) , highly expressed DE loci in only a single strain were omitted. 689
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